Log In
Print
BCIQ
Print
Print this Print this
 

Oxycyte

  Manage Alerts
Collapse Summary General Information
Company Tenax Therapeutics Inc.
DescriptionPerfluorocarbon-based IV therapeutic oxygen carrier
Molecular Target Not applicable
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationShock / trauma
Indication DetailsTreat hemorrhagic shock; Treat traumatic brain injury (TBI)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today